NASDAQ:PDLI PDL BioPharma (PDLI) Stock Price, News & Analysis → The 1,000X Crypto Playbook (From True Market Insiders) (Ad) Free PDLI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$2.47▼$2.4750-Day Range$2.47▼$2.4752-Week Range$2.09▼$3.86VolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get PDL BioPharma alerts: Email Address Ad True Market InsidersCrypto Bull Market – Or Crypto Crash on The Horizon?Are We Headed for a Historic Crypto Bull Run… OR… Crypto Crash?Click For My #1 FREE Crypto for 2024 About PDL BioPharma Stock (NASDAQ:PDLI)PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.Read More Ad True Market InsidersCrypto Bull Market – Or Crypto Crash on The Horizon?Are We Headed for a Historic Crypto Bull Run… OR… Crypto Crash?Click For My #1 FREE Crypto for 2024 PDLI Stock News HeadlinesFebruary 23, 2024 | morningstar.comGT Biopharma Inc GTBPOctober 24, 2023 | thestreet.comHealth Winners & Losers: MaxygenApril 17, 2024 | True Market Insiders (Ad)Crypto Bull Market – Or Crypto Crash on The Horizon?Are We Headed for a Historic Crypto Bull Run… OR… Crypto Crash?October 18, 2023 | investing.comPDLI Historical DataJune 28, 2023 | finance.yahoo.comABVC - ABVC BioPharma, Inc.June 23, 2023 | finance.yahoo.comRDHL - RedHill Biopharma Ltd.March 12, 2023 | seekingalpha.comLABPJanuary 15, 2023 | msn.comA Persons Deprived of Liberty (PDL) interacts with his pet mouse inside the jailApril 17, 2024 | True Market Insiders (Ad)Crypto Bull Market – Or Crypto Crash on The Horizon?Are We Headed for a Historic Crypto Bull Run… OR… Crypto Crash?January 4, 2023 | thestreet.comPDL BioPharma Stock To Go Ex-dividend Monday (PDLI)December 14, 2022 | thestreet.comPDL BioPharma Stock To Go Ex-dividend Tomorrow (PDLI)August 6, 2022 | thestreet.comCramer's 'Mad Money' Recap: Politics Is OverratedMay 21, 2022 | forbes.comSteris (STE)See More Headlines Receive PDLI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PDL BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/06/2020Today4/17/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryBiotechnology Current SymbolNASDAQ:PDLI CUSIP69329Y10 CIK882104 Webwww.pdl.com Phone775-832-8500Fax775-832-8501Employees109Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableOptionable BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Dominique P. Monnet (Age 59)CEO, Pres & Director Comp: $1.2MMr. Edward A. Imbrogno CPA (Age 55)VP, CFO & Chief Accounting Officer Comp: $564.14kMr. Christopher L. Stone (Age 56)VP, Gen. Counsel & Sec. Comp: $1.15MMr. Nathan KryszakDeputy Gen. Counsel & Assistant Sec.Key CompetitorsAlvotechNYSE:ALVOGenocea BiosciencesNASDAQ:GNCAQVectivBioNASDAQ:VECT180 Life SciencesNASDAQ:ATNFW60 Degrees PharmaceuticalsNASDAQ:SXTPWView All Competitors PDLI Stock Analysis - Frequently Asked Questions How were PDL BioPharma's earnings last quarter? PDL BioPharma, Inc. (NASDAQ:PDLI) posted its earnings results on Thursday, August, 6th. The biotechnology company reported ($0.43) EPS for the quarter, missing analysts' consensus estimates of $0.10 by $0.53. The biotechnology company earned $5.21 million during the quarter. What other stocks do shareholders of PDL BioPharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other PDL BioPharma investors own include AT&T (T), OPKO Health (OPK), Advanced Micro Devices (AMD), Novavax (NVAX), General Electric (GE), Teva Pharmaceutical Industries (TEVA), Bank of America (BAC), Bausch Health Companies (BHC) and Cara Therapeutics (CARA). This page (NASDAQ:PDLI) was last updated on 4/17/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe 1,000X Crypto PlaybookTrue Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe “Perfect Storm” for GoldGold Safe ExchangeThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchPrepare for a recession unlike any otherAmerican Hartford Gold GroupIRS Loophole Gives Americans An Escape From InflationBirch Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PDL BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.